Bronquidiazina CR Suspension

Bronquidiazina CR is a well-known pharmaceutical medication primarily marketed in Spain for the treatment of respiratory tract infections accompanied by bronchospasm or cough. It combines sulfamethoxazole, trimethoprim, bromhexine, and other active ingredients to address bacterial infections and facilitate mucus clearance.

The medication is produced and marketed by Laboratorios FAES Farma S.A., a major Spanish pharmaceutical company founded in 1933 in Bilbao, Spain. FAES Farma develops, manufactures, and commercializes prescription pharmaceuticals and healthcare products internationally. Its primary manufacturing facilities and corporate headquarters are located in the Basque Country and Madrid, Spain, where products such as Bronquidiazina CR are produced.